BMYMP Stock DD Bristol-Myers Squibb Co. 08/01/2014 09:17:45

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
BMYMP Bristol-Myers Squibb Co. $BMYMP Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=BMYMP&am...mp;yt0=Go!

Last Updated: 08/01/2014 09:17:41

Current Price and Quotes
Last Price 860.00
Previous Close 860.00 Open N/A
Daily Range N/A - N/A 52wk Range 750.00 - 1,079.20
Volume 0 Dividend 2.00
Average Vol (3m) 32 Yield 0.232558




Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 16,385,000 17,621,000 21,244,000 19,484,000
Cost of Revenue 4,619,000 4,610,000 5,598,000 5,277,000
Gross Profit 11,766,000 13,011,000 15,646,000 14,207,000
Operating Expenses

Research and Development 3,731,000 3,904,000 3,839,000 3,566,000
Sales, General and Admin. 4,939,000 5,017,000 5,160,000 4,663,000
Non-Recurring Items - 1,830,000 - -
Other - - - -
Operating Income 3,096,000 2,260,000 6,647,000 5,978,000
Income From Continuing Operations

Add'l Income/Expense Items (205,000) 80,000 334,000 93,000
Earnings Before Interest and Tax 2,891,000 2,340,000 6,981,000 6,071,000
Interest Expense - - - -
Earnings Before Tax 2,891,000 2,340,000 6,981,000 6,071,000
Income Tax 311,000 (161,000) 1,721,000 1,558,000
Minority Interest 17,000 541,000 1,551,000 1,411,000
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 2,563,000 1,960,000 3,709,000 3,102,000
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 2,563,000 1,960,000 3,709,000 3,102,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 2,563,000 1,960,000 3,709,000 3,102,000

Recent News

Jul 29, 2014 European Commission Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and Prevention of Recurrent DVT and PE
Jul 25, 2014 The Zacks Analyst Blog Highlights:Starbucks, Dunkin' Brands, Bristol-Myers Squibb, AstraZeneca and Pfizer
Jul 24, 2014 BioMed Realty And Bristol-Myers Squibb Sign Lease To Expand Relationship To 194,100 Square Feet At Woodside Technology Park In Redwood City, California
Jul 24, 2014 Bristol-Myers Squibb Reports Second Quarter 2014 Financial Results
Jul 24, 2014 Bristol-Myers Squibb and Ono Pharmaceutical Co., Ltd. Announce Strategic Immuno-Oncology Collaboration in Japan, South Korea and Taiwan
Jul 21, 2014 Technical Pointers on Pharma Equities -- AbbVie, Johnson and Johnson, Merck, Bristol-Myers Squibb, and Eli Lilly
Jul 17, 2014 Bristol-Myers Squibb and Pfizer Announce Enrollment of First Patient in Phase IV EMANATE Trial to Assess Effectiveness and Safety of Eliquis(R) (apixaban) in Patients with NVAF Undergoing Cardioversion
Jul 16, 2014 International Coach Federation Video Spotlights Innovative Coach Training Program
Jul 15, 2014 The High Cost of Second-Generation TKIs for CML is an Obstacle to Effective Reimbursement and Patient Access at the National and Institutional Level in Both Brazil and Mexico
Jul 15, 2014 The Hepatitis C Virus Drug-Treated Population in the G7 Markets Will Reach Nearly Half a Million Cases in 2016

1
2
3
4
5
6
7
8
next >

BMYMP Bristol-Myers Squibb Co. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=BMYMP&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/BMYMP/quote
Stock Chart http://www.otcmarkets.com/stock/BMYMP/chart
Company Info http://www.otcmarkets.com/stock/BMYMP/company-info
Recent News http://www.otcmarkets.com/stock/BMYMP/news
Financials http://www.otcmarkets.com/stock/BMYMP/financials
Filings and Disclosure http://www.otcmarkets.com/stock/BMYMP/filings
Short Sales http://www.otcmarkets.com/stock/BMYMP/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/BMYMP/insider-transactions
Research Reports http://www.otcmarkets.com/stock/BMYMP/research
Summary http://finance.yahoo.com/q?s=BMYMP
Historical Prices http://finance.yahoo.com/q/hp?s=BMYMP+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=BMYMP
Basic Chart http://finance.yahoo.com/q/bc?s=BMYMP+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=BMYMP+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=BMYMP+Headlines
Press Releases http://finance.yahoo.com/q/p?s=BMYMP+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=BMYMP+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=BMYMP+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=BMYMP+Industry
Major Holders http://finance.yahoo.com/q/mh?s=BMYMP+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=BMYMP+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=BMYMP+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=BMYMP
Balance Sheet http://finance.yahoo.com/q/bs?s=BMYMP
Cash Flow http://finance.yahoo.com/q/cf?s=BMYMP+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/BMYMP
Market Watch http://www.marketwatch.com/investing/stock/BMYMP
Bloomberg http://www.bloomberg.com/quote/BMYMP:US
Morningstar http://quotes.morningstar.com/stock/s?t=BMYMP
Bussinessweek http://investing.businessweek.com/research/st...cker=BMYMP
Barchart http://www.barchart.com/quotes/stocks/BMYMP
OTC Short Report http://otcshortreport.com/index.php?index=BMYMP
Investopedia http://www.investopedia.com/markets/stocks/BMYMP/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Piedmont Orthopedics Expands Care in Henry County

Updated Category News Views 37

A Surgeon's Story Comes to Henry County Ah, the medical field. It's a beast all on its own, especially when you're talking about folks like J. Hunter Matthews, M.D. making waves in the orthopedic world. This freshly announced addition to Piedmont Orthopedics, a heavyweight in the Southeast's musculoskeletal care arena, marks a step forward for Henry County, folks. We're...

Continue Reading
Foodcare Proves Effective in Reducing Blood Sugar Levels

Updated Category News Views 6

A New Chapter for Diabetes Care: Foodcare Folks, we've got ourselves a game-changer in the world of diabetes care. Listen closely: Foodsmart's latest study, hot off the press from the American Heart Association's Circulation, essentially hands over the blueprint for tackling type 2 diabetes in an innovative fashion. Now, I'm not the type to get all mushy over scientific...

Continue Reading
Guaranteed Roof Expands with EM Exteriors through LB Capital

Updated Category News Views 5

A Bold Move to Elevate Roofing Standards In a move that seems to jolt the roofing industry awake, Guaranteed Roof is taking the wraps off its new strategic partnership with LB Capital and EM Exteriors. Think of it as a power trio aiming to redefine what roofing solutions should mean in the Southeast. It’s the kind of news that makes you sit up and ask, why now and why...

Continue Reading
EnGenius Names Experienced VP to Boost Sales Growth

Updated Category News Views 3

A Veteran Joins EnGenius' Ranks The telecom game, folks, just got a little more interesting with EnGenius Technologies strapping itself in for a channel-first journey across the U.S. and Canada. They've placed a seasoned player, Rachel Saunders, into the cockpit as Vice President of Sales, North America. Her resume reads like a telecom scout's dream: 17 years in electric...

Continue Reading
Donatos Targets Texas: Pushing Franchise Growth Limits

Updated Category News Views 7

Donatos Pizza: Ambitious Expansion in the Lone Star State When you think about pizza chains expanding, Donatos Pizza might not be the first name to come to mind, but they're cooking up something big in Texas. Folks in Dallas and Houston better be ready because Donatos is rolling out the red carpet for its edge-to-edge, topping-loaded pies all over Texas. Strategic Growth:...

Continue Reading
American Savings Bank Surges 6% on NYSE Debut

Updated Category News Views 6

American Savings Bank Lands with a Bang on NYSE Who would have thought American Savings Bank's (NYSE: ASBH) entry onto the stock market would start with such gusto? It's not every day you see a debut that impressive, with shares soaring 6.25% right out of the gate. Guess it's safe to say the folks over at ASBH did something right in the lead-up to their NYSE launch. CEO...

Continue Reading
Airswift's Strategic Acquisition Boosts U.S. Energy Presence

Updated Category News Views 6

What's Driving Airswift's Latest Expansion? Airswift just dropped a bombshell by snapping up key businesses from New Tech Global (NTG), marking a serious power move in the U.S. energy sector. Now, what does this actually mean for investors? In blunt terms: they're muscling up their contractor base by a meaty 30%. That's no small feat. It's a calculated step to ace the...

Continue Reading
Omneky Integrates AI Growth Agent With Slack for Ads

Updated Category News Views 5

Omneky's New Move: AI Growth Agent Meets Slack Picture this: You've got a marketing team hustling in the digital age, and now they've got a new ally. Omneky, the big-wig in autonomous AI growth, has snuck its AI Growth Agent right into Slack. This isn't just a party trick during Dreamforce week in San Francisco. This is Omneky throwing another cog into the advertising...

Continue Reading
Chad Tucker's Sequel Explores Deep Spiritual Themes

Updated Category News Views 6

An Honest Take: Faith, Growth, and Surrender A player in the world of spiritual growth literature has stepped up again, and it ain't holding back. Chad Tucker, a name perhaps familiar to folks following transformation tales soaked with faith, has released a beefy sequel to his first hit: The Lord in Us: If You Can Love an Enemy, You Can Love Anyone. Well, now he's back...

Continue Reading
Metriport Eyes Major Step in Health Data Integration

Updated Category News Views 6

Metriport's Push into the TEFCA Framework Son of a gun, Metriport's making noise in the health data world! They just got the nod as a Candidate QHIN under the Trusted Exchange Framework and Common Agreement, or TEFCA if you're into acronyms. This isn't just some digital high-five; it's a significant stride forward for healthcare data exchange. Now they're smack in the...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring ASC47: A Promising Therapy that Combines with Tirzepatide

Updated Category News Views 155

ASC47 and Tirzepatide Combination: A Breakthrough in Weight Management Recently, Ascletis Pharma Inc. has shared some exciting findings about its innovative treatment strategy for obesity, specifically involving the combination of ASC47 and tirzepatide. In studies conducted on diet-induced obese (DIO) mice, the duo demonstrated remarkable efficacy, leading to greater...

Continue Reading
Denali and Royalty Pharma Secure $275 Million Royalty Agreement

Updated Category News Views 156

Denali Therapeutics and Royalty Pharma Collaborate on Funding Deal Denali Therapeutics Inc. (NASDAQ: DNLI) and Royalty Pharma plc (NASDAQ: RPRX) have recently announced a significant synthetic royalty funding agreement worth $275 million. This deal is primarily focused on future net sales of the investigational medication tividenofusp alfa. This collaboration aims to...

Continue Reading
Kohler Resort's New Golf Course and Facility Upgrades

Updated Category News Views 359

Kohler Resort Introduces Exciting New Additions Kohler, a luxury hospitality destination, is embarking on an exciting new chapter of growth and innovation. This beautiful resort, famed for its world-class amenities and stunning natural surroundings, has announced several transformative additions to elevate guest experiences and positively impact the local community. A...

Continue Reading
CerraCap Backs MazeBolt's AI DDoS Platform Push

Updated Category News Views 14

Stepping Into the Cybersecurity Arena When giants like CerraCap Ventures make a move, you better believe there's something worth watching. Their recent investment in MazeBolt isn't just another line on a balance sheet—it's a bold statement about where cybersecurity is heading. This isn't child's play. We're talking next-gen resilience against DDoS threats, powered by...

Continue Reading
Investigation Launched into Simulations Plus, Inc. Shares

Updated Category News Views 183

Understanding the Securities Class Action Investigation The Rosen Law Firm, known for advocating for investor rights, has initiated an investigation concerning potential securities claims for shareholders of Simulations Plus, Inc. (NASDAQ: SLP). This action arises from allegations suggesting the company may have disseminated materially deceptive business information to...

Continue Reading